baricitinib

surface glycoprotein ; Severe acute respiratory syndrome coronavirus 2







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33639176 In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy. 2021 Apr 5
2 32809969 Baricitinib restrains the immune dysregulation in patients with severe COVID-19. 2020 Dec 1 1